Clinical trials: Pancreatectomy
Pancreatic Cancer, Resected, Diarrhea
Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
By 2030, pancreatic cancer is projected to become the second leading cause of cancer-related deaths, with a 5-year survival rate below 10%.
- Trial name
- FMT-TP (NCT06960122)
- Testing
- Fecal Microbiota Transplant (FMT), Standard Therapy
- Where
- China
- Volunteers
- 10 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine